共 50 条
- [2] USE OF HIGH-DOSE METHYLPREDNISOLONE IN COMBINATION WITH METOCLOPRAMIDE TO PREVENT CISPLATIN-INDUCED EMESIS SEMAINE DES HOPITAUX, 1988, 64 (19): : 1315 - 1317
- [3] THE BENEFIT AND RISK OF HIGH-DOSE METOCLOPRAMIDE IN COMPARISON TO HIGH-DOSE HALOPERIDOL OR TRIFLUPROMAZINE IN CISPLATIN-INDUCED EMESIS KLINISCHE WOCHENSCHRIFT, 1985, 63 (09): : 428 - 432
- [5] CONTINUOUS VERSUS INTERMITTENT INFUSION OF HIGH-DOSE METOCLOPRAMIDE IN PREVENTION OF CISPLATIN-INDUCED EMESIS LANCET, 1992, 340 (8819): : 619 - 619
- [7] COMPARISON OF THE ANTIEMETIC EFFICACY OF 2 HIGH-DOSE BENZAMIDES, METOCLOPRAMIDE AND ALIZAPRIDE, AGAINST CISPLATIN-INDUCED EMESIS CANCER TREATMENT REPORTS, 1985, 69 (11): : 1301 - 1303
- [8] A RANDOMIZED TRIAL OF HIGH-DOSE BOLUS METOCLOPRAMIDE VERSUS LOW-DOSE CONTINUOUS INFUSION METOCLOPRAMIDE IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (03): : 253 - 256